Linda Schäker-Hübner

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Histone Deacetylase

Endoplasmic Reticulum Stress

Drug Administration

Top Venues

Pharmaceuticals (Basel, Switzerland)

Chemical communications (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Fabian B Kraft, Maria Hanl, Felix Feller, Linda Schäker-Hübner, Finn K Hansen
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Fabian B Kraft, Maria Hanl, Felix Feller, Linda Schäker-Hübner, Finn K Hansen
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Fabian B Kraft, Maria Hanl, Felix Feller, Linda Schäker-Hübner, Finn K Hansen
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Oliver Clauß, Linda Schäker-Hübner, Barbara Wenzel, Magali Toussaint, Winnie Deuther-Conrad, Daniel Gündel, Rodrigo Teodoro, Sladjana Dukić-Stefanović, Friedrich-Alexander Ludwig, Klaus Kopka, Peter Brust, Finn K Hansen, Matthias Scheunemann
Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [ 18 F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Tim Keuler, Beate König, Nico Bückreiß, Fabian B Kraft, Philipp König, Linda Schäker-Hübner, Christian Steinebach, Gerd Bendas, Michael Gütschow, Finn K Hansen
Development of the first non-hydroxamate selective HDAC6 degraders. Chemical communications (Cambridge, England) 58 (79) (2022)